| # | Drug | Count |
|---|---|---|
| 0 | APREMILAST | 2 |
| 1 | GUSELKUMAB | 2 |
| 2 | TACROLIMUS | 2 |
| 3 | ADALIMUMAB | 1 |
| 4 | BOSENTAN | 1 |
| 5 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 1 |
| 6 | CYTARABINE | 1 |
| 7 | DAPAGLIFLOZIN | 1 |
| 8 | ENTECAVIR | 1 |
| 9 | ERLOTINIB HYDROCHLORIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GUSELKUMAB | 2 | 0.0002 |
| 1 | PIPERACILLIN AND TAZOBACTAM | 1 | 0.0001 |
| 2 | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | 1 | 0.0001 |
| 3 | ENTECAVIR | 1 | 0.0001 |
| 4 | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | 1 | 0.0001 |
| 5 | DAPAGLIFLOZIN | 1 | 0.0001 |
| 6 | LINEZOLID | 1 | 0.0001 |
| 7 | MEROPENEM | 1 | 0.0000 |
| 8 | SILDENAFIL POWDER, | 1 | 0.0000 |
| 9 | SILDINAFIL | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0001 |
| 1 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | l-Thyroxine [EPC] | 1 | 0.0000 |
| 6 | Interferon beta [EPC] | 1 | 0.0000 |
| 7 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Opioid Agonist [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |